Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGEN
#922
Repligen Corporation - Common Stock
176.2
7
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.16%
Monthly Change
+22.69%
6 month change
+39.60%
Year Change
+6.39%
Previous Close
182.0
3
Open
176.2
7
Low
176.2
7
High
176.2
7
Volume
106
Markets
US Stock Market
Healthcare
Medical Instruments & Supplies
RGEN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
54.77 M
55.33 M
55.56 M
55.77 M
56.15 M
56.33 M
56.44 M
Valuation ratios
Enterprise value
9.78 B
14.05 B
8.48 B
9.83 B
7.85 B
8.66 B
9.61 B
Price to earnings ratio
172.64
118.23
50
242.28
-312.91
190.53
244.7
Price to sales ratio
28.2
22.62
0.01
0.02
0.01
0.01
—
Price to cash flow ratio
164.91
127.43
0.05
0.09
0.05
0.08
0.14
Price to book ratio
6.75
8.67
0
0.01
0
0
0
Enterprise value to EBITDA ratio
90.72
64.66
30.55
78.54
156.46
57.53
—
Profitability ratios
Return on assets %
0.03
0.05
0.07
0.01
-0.01
0.02
0
Return on equity %
0.04
0.07
0.1
0.02
-0.01
0.02
0
Return on invested capital %
26.58
38.03
43.3
7.38
-6.66
9.24
1.08
Gross margin %
57.23
58.35
56.85
44.59
43.29
52.32
53.91
Operating margin %
19.06
24.94
28.03
8.54
-5.53
7.47
6.85
EBITDA margin %
29.43
32.4
34.62
19.59
7.91
20.4
13.69
Net margin %
16.36
19.13
23.2
6.51
-4.02
6.62
2.45
Liquidity ratios
Quick ratio
2.53
1.99
1.88
5.75
7.28
7.12
7.64
Current ratio
2.83
2.48
2.47
7.02
8.41
8.37
9.05
Inventory turnover
2.09
2
1.64
1.61
2.08
2.07
0.5
Asset turnover
0.22
0.31
0.33
0.24
0.22
0.25
0.07
Solvency ratios
Debt to assets ratio
—
—
—
0.21
0.19
—
—
Debt to equity ratio
—
—
—
0.29
0.27
—
—
Long term debt to total assets ratio
0.13
0.11
0.11
0.21
0.19
0.18
0.19
Long term debt to total equity ratio
0.16
0.15
0.15
0.29
0.27
0.26
0.26
Per share metrics
Operating cash flow per share
1.16
2.08
2 995.09
2 020.65
3 135.56
2 075.94
1 306.35
EBIT per share
1.3
2.92
3 910.36
968.05
-627.74
975.35
614.05
EBITDA per share
2
3.79
4 829.61
2 219.42
896.97
2 662.84
1 495.69
Total debt per share
—
—
—
10.28 K
9 395.7
—
—
Cash per share
13.31
10.54
10.86 K
13.33 K
13.54 K
17.14 K
17.91
Net current asset value per share
16.74
16.27
17.37 K
19.71 K
19.06 K
20.11 K
21.2
Tangible book value per share
28.37
30.56
33.26 K
34.96 K
35.27 K
37.24 K
37.29
Working capital per share
10.83
9.72
10.34 K
16.9 K
16.79 K
17.71 K
18.85
Book value per share
28.37
30.56
33.26 K
34.96 K
35.27 K
37.24 K
37.29
News
Why Is Viking Therapeutics (VKTX) Up 2.3% Since Last Earnings Report?
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
5 Biotech Stocks Worth Adding to Your Portfolio Now
J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Acadia Gets European Commission Nod for Daybu in Rett Syndrome
HALO Stock Rises 36% in a Month: Here's What You Should Know
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises
MRK/MRNA's Personalized Cancer Therapy Delivers First Phase III Win
RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos